301 related articles for article (PubMed ID: 25542862)
1. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
2. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.
Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S
Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609
[TBL] [Abstract][Full Text] [Related]
3. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.
Chen H; Lee JS; Liang X; Zhang H; Zhu T; Zhang Z; Taylor ME; Zahnow C; Feigenbaum L; Rein A; Sukumar S
Cancer Res; 2008 May; 68(10):3637-44. PubMed ID: 18463397
[TBL] [Abstract][Full Text] [Related]
4. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
5. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
7. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
8. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.
Jin K; Park S; Teo WW; Korangath P; Cho SS; Yoshida T; Győrffy B; Goswami CP; Nakshatri H; Cruz LA; Zhou W; Ji H; Su Y; Ekram M; Wu Z; Zhu T; Polyak K; Sukumar S
Cancer Discov; 2015 Sep; 5(9):944-59. PubMed ID: 26180042
[TBL] [Abstract][Full Text] [Related]
9. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 induces STAT3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells.
Azuma K; Sakamoto M; Katayama S; Matsui A; Nakamichi K; Goshima N; Watanabe S; Nakayama J; Semba K
Genes Cells; 2023 Apr; 28(4):277-287. PubMed ID: 36659836
[TBL] [Abstract][Full Text] [Related]
11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
12. HoxB7 PROMOTES GROWTH AND METASTASIS OF LUNG ADENOCARCINOMA CELLS THROUGH REGULATION OF THE TGF-β/SMAD3 SIGNALING.
Zhuang L; Li WH; Li K; Mao Y; Gao CL; Zhang C
J Biol Regul Homeost Agents; 2015; 29(3):601-8. PubMed ID: 26403398
[TBL] [Abstract][Full Text] [Related]
13. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HOXB7 protein reduces sensitivity of oral cancer cells to chemo-radiotherapy.
Yuan Z; Chen D; Chen X; Yang H; Wei Y
Cancer Gene Ther; 2016 Dec; 23(12):419-424. PubMed ID: 27834359
[TBL] [Abstract][Full Text] [Related]
15. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
16. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
Li YJ; Liu G; Xia L; Xiao X; Liu JC; Menezes ME; Das SK; Emdad L; Sarkar D; Fisher PB; Archer MC; Zacksenhaus E; Ben-David Y
Oncotarget; 2015 Nov; 6(35):36943-54. PubMed ID: 26460950
[TBL] [Abstract][Full Text] [Related]
18. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
19. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
[TBL] [Abstract][Full Text] [Related]
20. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]